Cell cycle times of short-term cultures of brain cancers as predictors of survival

British Journal of Cancer

Volumn 99, Issue 10, 2008, Pages 1678-1683

  Furneaux, C E ^a   Marshall, E S ^b   Yeoh, K ^a   Monteith, S J ^a,d   Mews, P J ^a   Sansur, C A ^a,d   Oskouian, R J ^a,d   Sharples, K J ^c   Baguley, B C ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Glioblastoma; Melanoma; Paclitaxel; Primary culture; Tpot

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN CANCER; CANCER CELL CULTURE; CANCER SURVIVAL; CELL CYCLE; CELL KINETICS; CHILD; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; MEDULLOBLASTOMA; MELANOMA; METASTASIS; OLIGODENDROGLIOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CELL CYCLE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 55949088546     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604716     Document Type: Article

References (19)

1. Baguley BC, Marshall ES (2004) In vitro modelling of human tumour behaviour in drug discovery programmes. Eur J Cancer 40: 794-801
2. Baguley BC, Marshall ES, Christmas TI (2002) Cultures of surgical material from lung cancers. A kinetic approach. In Lung Cancer, Molecular Pathology Methods and Reviews, Driscoll B (ed), Vol. 1, pp 527-544. Humana Press: Totowa, New Jersey
3. Baguley BC, Marshall ES, Whittaker JR, Dotchin MC, Nixon J, McCrystal MR, Finlay GJ, Matthews JH, Holdaway KM, van Zijl P (1995) Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer. Eur J Cancer 31A: 230-237
4. Basse B, Baguley BC, Marshall ES, Joseph WR, van Brunt B, Wake G, Wall DJ (2003) A mathematical model for analysis of the cell cycle in cell lines derived from human tumors. J Math Biol 47: 295-312
5. Basse B, Baguley BC, Marshall ES, Joseph WR, van Brunt B, Wake GC, Wall D (2004a) Modelling cell death in human tumour cell lines exposed to the anticancer drug paclitaxel. J Math Biol 49: 329-357
6. Basse B, Baguley BC, Marshall ES, Wake GC, Wall DJ (2004b) Modelling cell population growth with applications to cancer therapy in human tumour cell lines. Prog Biophysics Mol Biol 85: 353-368
7. Danova M, Riccardi A, Gaetani P, Wilson GD, Mazzini G, Brugnatelli S, Buttini R, Butti G, Ucci G, Paoletti P (1988) Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry. Eur J Cancer Clin Oncol 24: 873-880
8. Haustermans K, Fowler JF (2001) Is there a future for cell kinetic measurements using IdUrd or BdUrd? Int J Radiat Oncol Biol Phys 49: 505-511
9. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS (2002) Cyclin E and survival in patients with breast cancer. New Engl J Med 347: 1566-1575
10. Kim R, Emi M, Tanabe K (2006) Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology 119: 254-264
11. Marshall E, Baguley B, Evans B, Matthews J, McCrystal M, Vaughan M, Nixon J, Smeeton I, Whittaker J (2002) Short term culture of ovarian cancer cells: preliminary clinical correlation. In Ninth Biennial Meeting of the International Gynecologic Cancer Society, Mok JE (ed), pp 173-176. Monduzzi Editore: Bologna
12. Marshall ES, Baguley BC, Matthews JHL, Jose C, Furneaux CE, Shaw JHF, Kirker JA, Morton RP, White JB, Rice ML, Isaacs RJ, Coutts JR, Whitakker JR (2003) Estimation of radiation-induced interphase cell death in cultures of human tumor material and in cell lines. Oncol Res 14: 297-304
13. Marshall ES, Finlay GJ, Matthews JH, Shaw JH, Nixon J, Baguley BC (1992) Microculture-based chemosensitivity testing: a feasibility study comparing freshly explanted human melanoma cells with human melanoma cell lines. J Natl Cancer Inst 84: 340-345
14. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63: 1602-1607
15. Rew DA, Wilson GD (2000) Cell production rates in human tissues and tumours and their significance. Part II: clinical data. Eur J Surg Oncol 26: 405-417
16. Struikmans H, Rutgers DH, Jansen GH, Tulleken CAF, van der Tweel I, Battermann JJ (1998) Prognostic relevance of cell proliferation markers and DNA-ploidy in gliomas. Acta Neurochir (Wien) 140: 140-147
17. Tannock I (1978) Cell kinetics and chemotherapy: a critical review. Cancer Treat Rep 62: 1117-1133
18. Watson JV (1991) Tumour growth dynamics. Br Med Bull 47: 47-63
19. Wilson GD, McNally NJ, Dische S, Saunders MI, Des Rochers C, Lewis AA, Bennett MH (1988) Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine in corporation and flow cytometry. Br J Cancer 58: 423-431